Skip to main content
PMC home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1999 Aug;80(11):1734–1737. doi: 10.1038/sj.bjc.6690590

Role of a proteolysis-inducing factor (PIF) in cachexia induced by a human melanoma (G361)

P T Todorov 1, W N Field 1, M J Tisdale 1
PMCID: PMC2374268  PMID: 10468289

Abstract

Human melanoma, G361, which induces cachexia in nude mice, has been shown to produce a proteolysis-inducing factor (PIF) of Mr 24 000, which is immunologically identical to that isolated from a cachexia-inducing murine tumour (MAC16). Biosynthetic labelling of G361 cells using a combination of [35S]sulphate and [6-3H]glucosamine gave a single component of Mr 24 000 after affinity chromatography employing a murine monoclonal antibody. The material contained both radiolabels and, after digestion with peptide N-glycosidase F, two fragments were produced of Mr 14 000 and 10 000 also containing both radiolabels. Digestion with O-glycosidase produced three fragments of Mr 14 000, 6000 and 4000, the first two of which contained both radiolabels, while the third only contained 3H. This digestion pattern is the same as that previously observed with PIF from the MAC16 tumour and is commensurate with one N-linked sulphated oligosaccharide chain of Mr 10 000, one O-linked sulphated oligosaccharide chain of Mr 6000 and a central polypeptide chain of Mr 4000 with some residual carbohydrate. When PIF from G361 cells was administered to female NMRI mice (20 g) a pronounced depression of body weight (1.36 ± 0.36 g; P < 0.0001 from control) was observed over a 24 h period without a decrease in either food or water consumption. Body composition analysis showed a significant decrease in the non-fat carcass mass without a change in carcass fat or body water. This result suggests that depletion of lean body mass in mice bearing G361 melanoma arises from the production of PIF. © 1999 Cancer Research Campaign

Keywords: cancer cachexia, proteolysis-inducing factor, G361 melanoma, sulphated glycoprotein

Full Text

The Full Text of this article is available as a PDF (93.9 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Beutler B., Cerami A. Cachectin and tumour necrosis factor as two sides of the same biological coin. Nature. 1986 Apr 17;320(6063):584–588. doi: 10.1038/320584a0. [DOI] [PubMed] [Google Scholar]
  2. Cariuk P., Lorite M. J., Todorov P. T., Field W. N., Wigmore S. J., Tisdale M. J. Induction of cachexia in mice by a product isolated from the urine of cachectic cancer patients. Br J Cancer. 1997;76(5):606–613. doi: 10.1038/bjc.1997.433. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Dewys W. D., Begg C., Lavin P. T., Band P. R., Bennett J. M., Bertino J. R., Cohen M. H., Douglass H. O., Jr, Engstrom P. F., Ezdinli E. Z. Prognostic effect of weight loss prior to chemotherapy in cancer patients. Eastern Cooperative Oncology Group. Am J Med. 1980 Oct;69(4):491–497. doi: 10.1016/s0149-2918(05)80001-3. [DOI] [PubMed] [Google Scholar]
  4. Fearon K. C. The Sir David Cuthbertson Medal Lecture 1991. The mechanisms and treatment of weight loss in cancer. Proc Nutr Soc. 1992 Aug;51(2):251–265. doi: 10.1079/pns19920036. [DOI] [PubMed] [Google Scholar]
  5. Kajimura N., Iseki H., Tanaka R., Ohue C., Otsubo K., Gyoutoku M., Sasaki K., Akiyama Y., Yamaguchi K. Toxohormones responsible for cancer cachexia syndrome in nude mice bearing human cancer cell lines. Cancer Chemother Pharmacol. 1996;38 (Suppl):S48–S52. doi: 10.1007/s002800051038. [DOI] [PubMed] [Google Scholar]
  6. Lorite M. J., Cariuk P., Tisdale M. J. Induction of muscle protein degradation by a tumour factor. Br J Cancer. 1997;76(8):1035–1040. doi: 10.1038/bjc.1997.504. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Lundholm K., Edström S., Karlberg I., Ekman L., Scherstén T. Relationship of food intake, body composition, and tumor growth to host metabolism in nongrowing mice with sarcoma. Cancer Res. 1980 Jul;40(7):2516–2522. [PubMed] [Google Scholar]
  8. Marshall M. K., Doerrler W., Feingold K. R., Grunfeld C. Leukemia inhibitory factor induces changes in lipid metabolism in cultured adipocytes. Endocrinology. 1994 Jul;135(1):141–147. doi: 10.1210/endo.135.1.8013346. [DOI] [PubMed] [Google Scholar]
  9. Matthys P., Heremans H., Opdenakker G., Billiau A. Anti-interferon-gamma antibody treatment, growth of Lewis lung tumours in mice and tumour-associated cachexia. Eur J Cancer. 1991;27(2):182–187. doi: 10.1016/0277-5379(91)90483-t. [DOI] [PubMed] [Google Scholar]
  10. Metcalf D., Nicola N. A., Gearing D. P. Effects of injected leukemia inhibitory factor on hematopoietic and other tissues in mice. Blood. 1990 Jul 1;76(1):50–56. [PubMed] [Google Scholar]
  11. Moldawer L. L., Andersson C., Gelin J., Lundholm K. G. Regulation of food intake and hepatic protein synthesis by recombinant-derived cytokines. Am J Physiol. 1988 Mar;254(3 Pt 1):G450–G456. doi: 10.1152/ajpgi.1988.254.3.G450. [DOI] [PubMed] [Google Scholar]
  12. Mori M., Yamaguchi K., Abe K. Purification of a lipoprotein lipase-inhibiting protein produced by a melanoma cell line associated with cancer cachexia. Biochem Biophys Res Commun. 1989 May 15;160(3):1085–1092. doi: 10.1016/s0006-291x(89)80114-7. [DOI] [PubMed] [Google Scholar]
  13. Mori M., Yamaguchi K., Honda S., Nagasaki K., Ueda M., Abe O., Abe K. Cancer cachexia syndrome developed in nude mice bearing melanoma cells producing leukemia-inhibitory factor. Cancer Res. 1991 Dec 15;51(24):6656–6659. [PubMed] [Google Scholar]
  14. Smith K. L., Tisdale M. J. Mechanism of muscle protein degradation in cancer cachexia. Br J Cancer. 1993 Aug;68(2):314–318. doi: 10.1038/bjc.1993.334. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Strassmann G., Fong M., Kenney J. S., Jacob C. O. Evidence for the involvement of interleukin 6 in experimental cancer cachexia. J Clin Invest. 1992 May;89(5):1681–1684. doi: 10.1172/JCI115767. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Tarentino A. L., Gómez C. M., Plummer T. H., Jr Deglycosylation of asparagine-linked glycans by peptide:N-glycosidase F. Biochemistry. 1985 Aug 13;24(17):4665–4671. doi: 10.1021/bi00338a028. [DOI] [PubMed] [Google Scholar]
  17. Todorov P. T., Deacon M., Tisdale M. J. Structural analysis of a tumor-produced sulfated glycoprotein capable of initiating muscle protein degradation. J Biol Chem. 1997 May 9;272(19):12279–12288. doi: 10.1074/jbc.272.19.12279. [DOI] [PubMed] [Google Scholar]
  18. Todorov P. T., McDevitt T. M., Cariuk P., Coles B., Deacon M., Tisdale M. J. Induction of muscle protein degradation and weight loss by a tumor product. Cancer Res. 1996 Mar 15;56(6):1256–1261. [PubMed] [Google Scholar]
  19. Todorov P., Cariuk P., McDevitt T., Coles B., Fearon K., Tisdale M. Characterization of a cancer cachectic factor. Nature. 1996 Feb 22;379(6567):739–742. doi: 10.1038/379739a0. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES